Bezafibrate in men with lower extremity arterial disease – (11-21-02)

Bezafibrate in men with lower extremity arterial disease

This is just such a wonderful example of putting blinders on when we look at disease. Here we see a cholesterol lowering medication in action. Sure, it lowers cholesterol. But does it actually lower deaths from heart attacks and strokes? NOPE. It’s almost laughable if it wasn’t so serious. The approach to CVD prevention here in the US is to check cholesterol levels and medicate if needed (with the guidelines for who needs medication constantly widening…). OOPS. This study may blow a hole in conventional wisdom and treatment. Anyone surprised that this article is not getting the press that CRP levels are?

bmj.com Abstracts: Meade et al. 325 (7373): 1139

Click here for more information.

For more than a decade, Dr. Bogash has stayed current with the medical literature as it relates to physiology, disease prevention and disease management. He uses his knowledge to educate patients, the community and cyberspace on the best way to avoid and / or manage chronic diseases using lifestyle and targeted supplementation.







Email: